Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.

作者: Peng-fei Tang , Xiang Zheng , Xiao-xia Hu , Cheng-cheng Yang , Zhe Chen

DOI: 10.2147/DDDT.S268796

关键词:

摘要: Aim We aimed to systematically examine the effects of enzymatic activity 38 human CYP2C9 alleles and 21 CYP3A4 alleles, including wild-type CYP2C9.1 CYP3A4.1, which contain 24 novel (*36–*60) 6 (*28–*34) newly found in Chinese population, on sildenafil metabolism through vitro experiment. Methods The recombinant cytochrome P450 protein expressed insect baculovirus expression system were reacted with 10–500 µM for 30 minutes at 37°C, reaction was terminated by cooling −80°C immediately. Next, we used ultra-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) detection detect its active metabolite N-desmethyl sildenafil. Results intrinsic clearance (Vmax/Km) values most variants significantly altered when compared CYP2C9*1, these exhibiting either reduced Vmax and/or increased Km values. Four (CYP2C9*11, *14, *31, *49) exhibited no markedly decreased relative (1-fold). remaining thirty-three decrease different levels, ranging from 1.81% 88.42%. For metabolic pathway, CYP3A4*1, four (CYP3A4*3, *10, *14 *I335T) showed higher (130.7–134.9%), while five (CYP3A4*2, *5, *24, *L22V *F113I) sharply (1.80–74.25%), nine allelic statistical difference. In addition, kinetic parameters two (CYP3A4*17 CYP3A4*30) could not be detected, due defect gene. Conclusion These findings first evaluation all infrequent metabolism; treating people who carry variants, there should more focus relation dose intensity, side therapeutic efficacy administering sildenafil. study will provide fundamental data effect variation further clinical research.

参考文章(62)
Craig R Lee, CYP2C9 genotype as a predictor of drug disposition in humans. Methods and Findings in Experimental and Clinical Pharmacology. ,vol. 26, pp. 463- 472 ,(2004)
Sandra R. Leiblum, After sildenafil: bridging the gap between pharmacologic treatment and satisfying sexual relationships. The Journal of Clinical Psychiatry. ,vol. 63, pp. 17- 22 ,(2002)
R. Hyland, E. G. H. Roe, B. C. Jones, D. A. Smith, Identification of the cytochrome P450 enzymes involved in the N‐demethylation of sildenafil British Journal of Clinical Pharmacology. ,vol. 51, pp. 239- 248 ,(2001) , 10.1046/J.1365-2125.2001.00318.X
Ian Eardley, Peter Ellis, Mitradev Boolell, Maria Wulff, Onset and duration of action of sildenafil for the treatment of erectile dysfunction. British Journal of Clinical Pharmacology. ,vol. 53, ,(2002) , 10.1046/J.0306-5251.2001.00034.X
Joyce A. Goldstein, Diana Dai, Ernest Hodgson, Randy Rose, Jun Tang, Rachelle J. Bienstock, Harvey W. Mohrenweiser, Identification of Variants of CYP3A4 and Characterization of Their Abilities to Metabolize Testosterone and Chlorpyrifos Journal of Pharmacology and Experimental Therapeutics. ,vol. 299, pp. 825- 831 ,(2001)
Da-Peng Dai, Chuan-Bao Li, Shuang-Hu Wang, Jie Cai, Pei-Wu Geng, Yun-Fang Zhou, Guo-Xin Hu, Jian-Ping Cai, Identification and characterization of a novel CYP2C9 allelic variant in a warfarin-sensitive patient Pharmacogenomics. ,vol. 16, pp. 1475- 1486 ,(2015) , 10.2217/PGS.15.89
Bo Wang, Jing Wang, Shui-Qing Huang, Hai-Hao Su, Shu-Feng Zhou, Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance Current Drug Metabolism. ,vol. 10, pp. 781- 834 ,(2009) , 10.2174/138920009789895480
Jatinder K. Lamba, Yvonne S. Lin, Kenneth Thummel, Ann Daly, Paul B. Watkins, Stephen Strom, Jiong Zhang, Erin G. Schuetz, Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. ,vol. 12, pp. 121- 132 ,(2002) , 10.1097/00008571-200203000-00006
Keiko Maekawa, Hiromi Fukushima-Uesaka, Masahiro Tohkin, Ryuichi Hasegawa, Hiroshi Kajio, Nobuaki Kuzuya, Kazuki Yasuda, Manabu Kawamoto, Naoyuki Kamatani, Kazuko Suzuki, Tatsuo Yanagawa, Yoshiro Saito, Jun-ichi Sawada, Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese Pharmacogenetics and Genomics. ,vol. 16, pp. 497- 514 ,(2006) , 10.1097/01.FPC.0000215069.14095.C6